Virginia – The Fourth State to Ban Animal Testing in the U.S.
In the United States (U.S.), Virginia is the fourth state to ban animal testing in cosmetic products. The Governor of this state (Ralph Northam) has signed this month (March 2021) a bill and the ban will start on January 1st, 2022. The sale of cosmetics tested on animals will also be prohibited from July 1st, 2022.

SENATE BILL NO. 1379 – ANIMAL TESTING BAN

According to the Senate Bill No. 1379, starting January 1st, 2022, it will no longer be permitted to perform tests of cosmetic products on animals. Moreover, beginning July 1st, 2022, the sale of cosmetics tested on animals will also be banned.

The Humane Cosmetics Act “prohibits a cosmetics manufacturer from:

  • (i) conducting or contracting for cosmetic animal testing that occurs in the Commonwealth on or after January 1, 2022
  • (ii) manufacturing or importing to profit into the Commonwealth any cosmetic or ingredient thereof, if the cosmetics manufacturer knew or reasonably should have known that the cosmetic or any component thereof was developed or manufactured using cosmetic animal testing that was conducted on or after January 1, 2022;
  • (iii) beginning July 1, 2022, selling or offering for sale within the Commonwealth any cosmetic, if the cosmetics manufacturer knows or reasonably should know that the cosmetic or any component thereof was developed or manufactured using cosmetic animal testing that was conducted on or after January 1, 2022.”

Civil penalties will be applied to violations (up to $5,000 and an additional $1,000 for each day the violation continues).

There are four exceptions to this ban. Prohibitions do not apply to cosmetics for which the animal testing was:

  • Required by a federal or state regulatory authority and if:
    • (i) the test ingredient is in wide use and cannot be replaced by another ingredient (capable of performing similar function;
    • (ii) a specific human health problem is substantiated that justifies the need to conduct such animal testing (supported by a detail research protocol);
    • (iii) and does not exist an alternative testing method accepted for the relevant purpose (by the federal/state regulatory agency).
  • Required by a foreign jurisdiction or foreign regulatory agency, and conducted outside the U.S.
    • No evidence derived from such test shall be relied upon to substantiate the safety of the cosmetics sold in Virginia.
  • Conducted on any product/ingredient subject to the requirements of Subchapter V of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 351 et seq.); or
  • Required by a federal, state, or foreign regulatory agency for a purpose unrelated to cosmetics (subjected to conditions).

This ban in the state of Virginia is part of a greater effort to stop animal testing on a federal level. California, Nevada and Illinois are the three states that already banned the animal testing in cosmetic and personal care products. New York, Oregon, New Jersey, Maryland, Rhode Island and Hawaii are expected to pass similar laws.

Several other countries have also been making changes towards banning animal testing on cosmetic products and harmonizing its cosmetic regulations with the European Cosmetic Regulation ((EC) No 1223/2009).

References:

  1. Senate Bill No 1379 – Chapter 52, Humane Cosmetics Act – https://lis.virginia.gov/cgi-bin/legp604.exe?211+ful+SB1379

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »